Christopher Woods
Infectious Disease · Durham, NCNPI 1013004811
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,085 of the $16,069 with a category attached, or 93.9%. 3 manufacturers reported payments, led by Roche Diagnostics Corporation at 38.5% of the total. Among infectious disease clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $1460.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Diagnostics Corporation$6K
- Bavarian Nordic A/s$6K
- Regeneron$4K
Across 120 payments — averaging $8090.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$565K
- Pfizer$236K
- Abbott$156K
- Biomerieux Inc$10K
- Bavarian Nordic A/s$4K
What the payments were for
- Consulting fees$15,08594%
- Travel & lodging$9596%
- Food & beverage$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Diagnostics Corporation | 7 | $6,194 |
| Bavarian Nordic A/s | 2 | $5,750 |
| Regeneron | 2 | $4,125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,069 in reported general payments places this provider in the 90th percentile of 250 infectious disease providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $46,819 |
| CompleraEmtricita/Rilpivirine/Tenof Df | 11 | $39,138 |
| ValacyclovirValacyclovir Hcl | 16 | $1,386 |
| Sumatriptan Succinate | 12 | $49 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Durham
- Cristina GasparettoDurham$613K
- Cameron WolfeDurham$112K
- Gordon CoreyDurham$46K
- Mitchell HorwitzDurham$45K
- Vance FowlerDurham$43K
- Sonali AdvaniDurham$37K
- Steve TaylorDurham$8K
- Barbara AlexanderDurham$6K
- John PerfectDurham$6K
- Kara McGeeDurham$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.